Companies: 10,795·Total market cap: $144.5T
MJardin Group, Inc.

MJardin Group, Inc.

MJARFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$90140
P/E Ratio
52W High$0.0001
52W Low$0.000001

MJardin Group, Inc. (MJARF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

MJARF · earnings · updated Jun 15, 2026

No earnings history available.

Next Earnings Date

Days Away79
Expected DateSep 2, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.

EPS & Revenue vs. Estimates

Actual (Beat)
Actual (Miss)
Estimated

Earnings History

Q3 FY2026
Aug 6, 2026
EPS Actual
EPS Est.
-$0.02
EPS Surpr.
Revenue
Q2 FY2026
Jun 3, 2026
EPS Actual
EPS Est.
-$0.02
EPS Surpr.
Revenue
Q2 FY2026
Jun 3, 2026
EPS Actual
EPS Est.
EPS Surpr.
Revenue
Q1 FY2026
Feb 25, 2026
EPS Actual
EPS Est.
-$0.03
EPS Surpr.
Revenue
Q3 FY2024
Aug 8, 2024
EPS Actual
EPS Est.
EPS Surpr.
Revenue
Q2 FY2024
May 29, 2024
EPS Actual
EPS Est.
EPS Surpr.
Revenue
Q1 FY2024
Feb 28, 2024
EPS Actual
EPS Est.
EPS Surpr.
Revenue
Q4 FY2023
Nov 1, 2023
EPS Actual
EPS Est.
EPS Surpr.
Revenue

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
PeriodLowConsensusHigh# Analysts
Q3 FY2027$-0.02$-0.02$-0.021
Q2 FY2027$-0.02$-0.02$-0.021
Q1 FY2027$-0.03$-0.03$-0.031
Q4 FY2026$-0.02$-0.02$-0.021
Q3 FY2026$-0.02$-0.02$-0.021
Q2 FY2026$-0.03$-0.03$-0.031
Revenue Estimates
PeriodLowConsensusHigh# Analysts
Q3 FY2027$0.0B$0.0B$0.0B1
Q2 FY2027$0.0B$0.0B$0.0B1
Q1 FY2027$0.0B$0.0B$0.0B1
Q4 FY2026$0.0B$0.0B$0.0B1
Q3 FY2026$0.0B$0.0B$0.0B1
Q2 FY2026$0.0B$0.0B$0.0B1

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: MJARF ends December

MJardin Group, Inc. (MJARF) reports earnings quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. The next MJARF earnings date is expected around September 2, 2026.

Each quarter, investors track MJARF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MJARF revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MJARF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Frequently asked questions

MJARF earnings · 3 questions

MJardin Group, Inc.'s next earnings report is expected around September 2, 2026. MJARF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MJARF historically reports after market close (AMC).

MJARF earnings datewhen is MJARF earningsMJARF next earnings datewhen does MJARF report earningsMJARF earnings calendar

Source: FMP · MJardin Group, Inc. SEC filings · US GAAP · MJardin Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026